HCP's most recent trend suggests a bullish bias. One trading opportunity on HCP is a Bull Put Spread using a strike $32.50 short put and a strike $27.50 long put offers a potential 8.7% return on risk over the next 34 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $32.50 by expiration. The full premium credit of $0.40 would be kept by the premium seller. The risk of $4.60 would be incurred if the stock dropped below the $27.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for HCP is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for HCP is bullish.
The RSI indicator is at 71.43 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for HCP
4 Reasons Why You Should Add HCP to Your Portfolio Right Now
Mon, 12 Aug 2019 12:09:12 +0000
HCP's efforts to expand its medical office and life-science portfolio, a diversified and high-quality portfolio and favorable demographic trends make it an attractive pick.
Edited Transcript of HCP earnings conference call or presentation 1-Aug-19 4:00pm GMT
Fri, 02 Aug 2019 21:45:00 +0000
Q2 2019 HCP Inc Earnings Call
HCP Inc (HCP) Q2 2019 Earnings Call Transcript
Thu, 01 Aug 2019 21:23:55 +0000
HCP earnings call for the period ending June 30, 2019.
HCP Surpasses Q2 FFO & Revenue Estimates, Raises Outlook
Thu, 01 Aug 2019 13:41:01 +0000
HCP witnesses rise in revenues and net operating income in the second quarter of 2019.
HCP (HCP) Q2 FFO and Revenues Beat Estimates
Wed, 31 Jul 2019 21:45:09 +0000
HCP (HCP) delivered FFO and revenue surprises of 2.33% and 9.98%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Also on Market Tamer…
Follow Us on Facebook